is wegovy a semaglutide or tirzepatide Drugmaker Cuts Price, but Doctors Still See Cost Challenges for Patients Zepbound Versus Wegovy: Head-to-Head Trial

Luca Perico, PhD, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy

Many patients achieve superior results by gradually increasing their GLP-1 dose to therapeutic levels rather than adding a second drug class

The program is designed for adults 18 and older who meet standard GLP-1 prescribing eligibility criteria - typically BMI 30 or higher, or BMI 27 or higher with at least one qualifying weight-related condition (such as hypertension, type 2 diabetes, dyslipidemia, or sleep apnea)

These improvements in cardiometabolic markers alongside lipid panel improvements including reduced triglycerides and LDL cholesterol make retatrutide particularly relevant for researchers studying metabolic syndrome and cardiovascular risk factor reduction

Shery to review goals and choose the best plan **COMPLIMENTARY VIRTUAL CONSULTATION** with our physician-led medical team to determine the most appropriate lab testing plan for you **COMPLIMENTARY** with our physician-led medical team to determine the most appropriate lab testing plan for you